<DOC>
	<DOCNO>NCT02036424</DOCNO>
	<brief_summary>To determine visual benefit Ozurdex treatment every three month compare monthly anti-VEGF alone , subject persistent diabetic macular edema . The investigator hypothesize frequent administration Ozurdex patient persistent diabetic macular edema result rapid sustain improvement visual acuity and/or optical coherence topography ( OCT ) compare use anti-VEGF alone .</brief_summary>
	<brief_title>Anti-Vascular Endothelial Growth Factor ( Anti-VEGF ) Alone Versus Ozurdex Given Every 3 Months Treatment Persistent Diabetic Macular Edema</brief_title>
	<detailed_description>Statistics throughout study refer number eye rather number subject . Subjects allow eye study provide inclusion/exclusion criterion meet . Five subject eye study ; 45 subject actually enrol , result 50 study eye .</detailed_description>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Endothelial Growth Factors</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>1 . Male female age 18 year old 2 . Type 1 Type 2 diabetes 3 . Best correct visual acuity ( BCVA ) score &gt; 24 &lt; 78 letter 4 . History least 3 antiVEGF intravitreal injection past 5 month 5 . Presence macular edema define central subfield thickness &gt; 340 micron Cirrus OCT 1 . AntiVEGF intravitreal treatment last 4 week 2 . Intravitreal steroid treatment last 8 week Ozurdex last 4 month 3 . Pan retinal photocoagulation ( PRP ) focal laser last 4 month 4 . Active iris neovascularization 5 . Any ocular condition study eye , opinion investigator , severe enough compromise study result 6 . Uncontrolled systemic disease 7 . Known history intraocular pressure ( IOP ) elevation response corticosteroid treatment , control 2 glaucoma medication 8 . Current enrollment investigational drug study participation study within 30 day prior baseline visit 9 . Female patient pregnant , nurse plan pregnancy childbearing potential use reliable mean contraception 10 . Any condition reason ( include inability read early treatment diabetic retinopathy study ( ETDRS ) chart language barrier ) preclude patient 's ability comply study requirement include completion study 11 . Patients active suspect ocular periocular infection include viral disease cornea conjunctiva , include active epithelial herpes simplex keratitis ( dendritic keratitis ) , vaccinia , varicella , mycobacterial infection , fungal disease . 12 . Aphakia pseudophakia anterior chamber intraocular lens 13 . Hypersensitivity component Ozurdex Avastin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>